Zimmer Biomet Holdings cut its 2025 organic revenue growth forecast following weakness in Latin America and emerging markets ...

Medical device company Zimmer Biomet (NYSE:ZBH) met Wall Streets revenue expectations in Q3 CY2025, with sales up 9.7% year ...

The orthopedic device maker posted revenue of $2 billion in the period, falling short of Street forecasts. Eight analysts surveyed by Zacks expected $2.01 billion. Zimmer expects full-year earnings in ...

The Workers' Compensation Benchmarking Study, the industry's largest claims management research initiative, has opened its 13th annual survey, inviting claims leaders to participate in essential ...

A rare shakeout in Big Tech and chip stocks on Tuesday rippled around world bourses overnight. The fact that it came with few ...

In a remarkable filing in both the Jim Comey and Letitia James cases, Attorney General Pam Bondi submitted a document she ...